Ripple’s Epidel Sustained Drug Platform: From Discovery to the Clinic
10:00 am - Wednesday 20th January 2027
- Discovery of the Epidel prodrug technology, and the systematic evaluation process that identified ophthalmology
- Building an ophthalmology-focused team from the ground up
- Generating preclinical and clinical proof-of-concept data sets robust enough to secure capital and anchor strategic partnerships
- Advancing proprietary pipeline programs in parallel with partnered development programs, sustaining internal innovation alongside strategic collaboration
